EUVIMEDEUVIMED entdecken
Crossref

Kidney‐Targeted Biomimetic Nanoparticles Loaded With Apolipoprotein H Alleviate Sepsis‐Associated Acute Kidney Injury by Inhibiting the TLR4 / NF ‐ κB Pathway

Lijun Zhu, Ruyi He, Jincong Xiao, Guoqiang Hu iD, Kuangzhang You, Suhuan Rao

Journal of Biomedical Materials Research Part A · 2026-08 · 114 (8)

DOI: 10.1002/jbm.a.70143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 11.08.2026. Verfasst von Lijun Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Sepsis, Toll-Like Receptor 4, Nanoparticles. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Taizhou Science and Technology Project, Scientific Research Foundation of Taizhou Enze Medical Center (Group), Science and Technology Plan Project of Taizhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis‐associated acute kidney injury (SA‐AKI) is a common and life‐threatening complication of sepsis, whose high incidence and mortality severely impair patient prognosis. Existing anti‐AKI drugs exhibit limited efficacy due to their inability to efficiently target injured kidneys. Although kidney‐targeted nanocarrier delivery systems show potential, exogenous nanoparticles are rapidly cleared by the immune system, resulting in a short blood circulatory half‐life and unsatisfactory targeting efficiency. Recombinant apolipoprotein H (rAPOH) exhibits anti‐apoptotic and anti‐inflammatory activities, holding promise for SA‐AKI treatment; however, its efficacy is constrained by insufficient targeting capability and rapid in vivo metabolic clearance. In this study, we constructed a biomimetic delivery system (KMA@rAPOH) consisting of A@rAPOH nanoparticles coated with kidney‐targeting peptide‐functionalized renal tubular epithelial cell membranes to realize targeted rAPOH delivery for SA‐AKI therapy. The nanocarrier demonstrated satisfactory encapsulation efficiency, high drug loading capacity, and favorable controlled release, along with excellent long‐term stability in DMEM and deionized water. In vitro, KMA@rAPOH was efficiently internalized by renal tubular epithelial cells and exerted significant anti‐apoptotic and anti‐inflammatory effects. In a mouse model of SA‐AKI, KMA@rAPOH markedly alleviated renal pathological damage and inhibited cell apoptosis. Additionally, it reduced the proportion of CD11c + F4/80 + pro‐inflammatory macrophages in the renal CD45 + CD11b + population. Mechanistically, KMA@rAPOH was found to reduce TLR4 levels and inhibit NF‐κB p65 phosphorylation, accompanied by decreased secretion of pro‐inflammatory cytokines including TNF‐α, IL‐1β, and IL‐6. These observations indicate that the TLR4/NF‐κB cascade may partially mediate the renoprotective activity of KMA@rAPOH, and this biomimetic nanoplatform represents a promising targeted delivery strategy for the treatment of renal inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjurySepsisToll-Like Receptor 4NanoparticlesNF-kappa BBiomimetic MaterialsSignal TransductionAnimalsMiceMaleKidneyApoptosisHumansCell Line

Stichwörter der Autor:innen

TLR4/NF‐κB signaling pathwaybiomimetic nanoparticleskidney‐targeting peptidesepsis‐associated acute kidney injury

Substanzen

Toll-Like Receptor 4NF-kappa BTlr4 protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
  • Department of Anesthesiology, Linhai First People's Hospital, Linhai, Zhejiang, China.

ORCID-Profile: Guoqiang Hu

Förderung

  • Taizhou Science and Technology Project
  • Scientific Research Foundation of Taizhou Enze Medical Center (Group)
  • Science and Technology Plan Project of Taizhou

Zitieren

APA

Zhu, L., He, R., Xiao, J., Hu, G., You, K., & Rao, S. (2026). Kidney‐Targeted Biomimetic Nanoparticles Loaded With Apolipoprotein H Alleviate Sepsis‐Associated Acute Kidney Injury by Inhibiting the TLR4 / NF ‐ κB Pathway. Journal of Biomedical Materials Research Part A, 114(8). https://doi.org/10.1002/jbm.a.70143

Vancouver

Zhu L, He R, Xiao J, Hu G, You K, Rao S. Kidney‐Targeted Biomimetic Nanoparticles Loaded With Apolipoprotein H Alleviate Sepsis‐Associated Acute Kidney Injury by Inhibiting the TLR4 / NF ‐ κB Pathway. Journal of Biomedical Materials Research Part A. 2026;114(8). doi:10.1002/jbm.a.70143

BibTeX
@article{Zhu2026,
  author = {Zhu, Lijun and He, Ruyi and Xiao, Jincong and Hu, Guoqiang and You, Kuangzhang and Rao, Suhuan},
  title = {Kidney‐Targeted Biomimetic Nanoparticles Loaded With Apolipoprotein H Alleviate Sepsis‐Associated Acute Kidney Injury by Inhibiting the TLR4 / NF ‐ κB Pathway},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  volume = {114},
  number = {8},
  doi = {10.1002/jbm.a.70143}
}
Kostenlos starten →